Literature DB >> 22357552

Neurological disorders and the potential role for stem cells as a therapy.

Paul R Sanberg1, David J Eve, L Eduardo Cruz, Cesar V Borlongan.   

Abstract

Introduction Neurological disorders are routinely characterized by loss of cells in response to an injury or a progressive insult. Stem cells could therefore be useful to treat these disorders. Sources of data Pubmed searches of recent literature. Areas of agreement Stem cells exhibit proliferative capacity making them ideally suited for replacing dying cells. However, instead of cell replacement therapy stem cell transplants frequently appear to work via neurotrophic factor release, immunomodulation and upregulation of endogenous stem cells. Areas of controversy and areas timely for developing research Many questions remain with respect to the use of stem cells as a therapy, the answers to which will vary depending on the disorder to be treated and mode of action. Whereas the potential tumorigenic capability of stem cells is a concern, most studies do not support this notion. Further determination of the optimal cell type, and whether to perform allogeneic or autologous transplants warrant investigation before the full potential of stem cells can be realized. In addition, the use of stem cells to develop disease models should not be overlooked.

Entities:  

Mesh:

Year:  2012        PMID: 22357552      PMCID: PMC3577100          DOI: 10.1093/bmb/lds001

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  71 in total

1.  SHED: stem cells from human exfoliated deciduous teeth.

Authors:  Masako Miura; Stan Gronthos; Mingrui Zhao; Bai Lu; Larry W Fisher; Pamela Gehron Robey; Songtao Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

3.  Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice.

Authors:  William V Nikolic; Huayan Hou; Terrence Town; Yuyan Zhu; Brian Giunta; Cyndy D Sanberg; Jin Zeng; Deyan Luo; Jared Ehrhart; Takashi Mori; Paul R Sanberg; Jun Tan
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

4.  Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury.

Authors:  Eva Syková; Ales Homola; Radim Mazanec; Hynek Lachmann; Simona Langkramer Konrádová; Petr Kobylka; Radek Pádr; Jirí Neuwirth; Vladimír Komrska; Vladimir Vávra; Jan Stulík; Martin Bojar
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

5.  Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease.

Authors:  Cesario V Borlongan; Christopher G Thanos; Steven J M Skinner; Marilyn Geaney; Dwaine F Emerich
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

6.  Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.

Authors:  Cesar V Borlongan; Martin Hadman; Cyndy Davis Sanberg; Paul R Sanberg
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

7.  Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice.

Authors:  Piotr Walczak; Ning Chen; David Eve; Jennifer Hudson; Tanja Zigova; Juan Sanchez-Ramos; Paul R Sanberg; Cyndy D Sanberg; Alison E Willing
Journal:  Brain Res Bull       Date:  2007-07-10       Impact factor: 4.077

Review 8.  A review of Parkinson's disease.

Authors:  C A Davie
Journal:  Br Med Bull       Date:  2008-04-08       Impact factor: 4.291

9.  The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

Authors:  Nancy M Joseph; Jack T Mosher; Johanna Buchstaller; Paige Snider; Paul E McKeever; Megan Lim; Simon J Conway; Luis F Parada; Yuan Zhu; Sean J Morrison
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

10.  Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain.

Authors:  Adam D Bachstetter; Mibel M Pabon; Michael J Cole; Charles E Hudson; Paul R Sanberg; Alison E Willing; Paula C Bickford; Carmelina Gemma
Journal:  BMC Neurosci       Date:  2008-02-14       Impact factor: 3.288

View more
  13 in total

1.  Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.

Authors:  Ike dela Peña; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2015-12       Impact factor: 6.829

Review 2.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

Review 3.  Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.

Authors:  Paolina Pantcheva; Stephanny Reyes; Jaclyn Hoover; Sussannah Kaelber; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-09-22       Impact factor: 4.618

Review 4.  Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier.

Authors:  Gabriel S Gonzales-Portillo; Paul R Sanberg; Max Franzblau; Chiara Gonzales-Portillo; Theo Diamandis; Meaghan Staples; Cyndy D Sanberg; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2014-01-29       Impact factor: 4.064

5.  Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines.

Authors:  Naoki Tajiri; David M Quach; Yuji Kaneko; Stephanie Wu; David Lee; Tina Lam; Ken L Hayama; Thomas G Hazel; Karl Johe; Michael C Wu; Cesar V Borlongan
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 6.  Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review.

Authors:  Larissa T Alvarim; Leopoldo P Nucci; Javier B Mamani; Luciana C Marti; Marina F Aguiar; Helio R Silva; Gisele S Silva; Mariana P Nucci-da-Silva; Elaine A DelBel; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2014-08-11

7.  Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke.

Authors:  Sandra A Acosta; Naoki Tajiri; Jaclyn Hoover; Yuji Kaneko; Cesar V Borlongan
Journal:  Stroke       Date:  2015-07-28       Impact factor: 7.914

Review 8.  Improvements in biomaterial matrices for neural precursor cell transplantation.

Authors:  Nolan B Skop; Frances Calderon; Cheul H Cho; Chirag D Gandhi; Steven W Levison
Journal:  Mol Cell Ther       Date:  2014-07-01

9.  Stem cell transplantation for neuroprotection in stroke.

Authors:  Kazutaka Shinozuka; Travis Dailey; Naoki Tajiri; Hiroto Ishikawa; Yuji Kaneko; Cesar V Borlongan
Journal:  Brain Sci       Date:  2013-07-03

10.  An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.

Authors:  Travis Dailey; Christopher Metcalf; Yusef I Mosley; Robert Sullivan; Kazutaka Shinozuka; Naoki Tajiri; Mibel Pabon; Sandra Acosta; Yuji Kaneko; Harry van Loveren; Cesar V Borlongan
Journal:  J Clin Med       Date:  2013-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.